|
|
|
|
|
|
|
|
|
|
medical news
"The anticancerous strategies targeting this protein (TRAP1) could therefore have adverse effects on tumors capable of promoting one metabolic pathway over another according to their needs. While simultaneously inhibiting cell proliferation, this type of treatment could actually stimulate progression into a metastatic state. "
a reference (open access):
Molecular Cancer 2012
Research
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.